SLC38A3 and non-small cell lung carcinoma: As another pivotal l-glutamine transporter, SLC38A3 demonstrates marked upregulation in metastatic NSCLC cells, with its expression levels intricately associated with the prognostic outcomes of NSCLC patients [73].